Live feed07:00:00·1362dPRReleasevia QuantisnowApellis Announces Four Oral Presentations of Data from the Phase 3 DERBY and OAKS Studies of Pegcetacoplan in Geographic Atrophy (GA) to be Presented at the American Academy of Ophthalmology Annual MeetingByQuantisnow·Wall Street's wire, on your screen.APLS· Apellis Pharmaceuticals Inc.Health Care
